Dr Reddys Lab settles Clarinex drug dispute; stk down

Published on Wed, Dec 24, 2008 at 11:17 |  Source : Moneycontrol.com

Updated at Wed, Dec 24, 2008 at 11:19  

27054 Investors following Dr Reddys Labs. Share this News with them.
0
0
Share on Tumblr

ALSO READ

Dr Reddys Laboratories had touched an intraday high of Rs 478 and an intraday low of Rs 455. At 11:07 am, the share was quoting at Rs 456.50, down Rs 11.5, or 2.46%.

The company has settled Clarinex drug dispute with Schering Corporation & Sepracor Inc, reports CNBC-TV18.
 
It was trading with volumes of 17,224 shares. Yesterday the share closed down 1.68% or Rs 8 at Rs 468.

Share Price Movement During The Last 12 Months
Period Price Latest Price Gain/Loss (Rs.) % Gain/Loss
3-Days 474.00 456.50 -17.50 -3.69
5-Days 441.25 456.50 15.25 3.46
7-Days 452.60 456.50 3.90 0.86
15-Days 481.20 456.50 -24.70 -5.13
1-Month 429.70 456.50 26.80 6.24
3-Month 522.95 456.50 -66.45 -12.71
6-Month 646.80 456.50 -190.30 -29.42
9-Month 564.90 456.50 -108.40 -19.19
1-Year 719.70 456.50 -263.20 -36.57

  

More on Moneycontrol

Trending News

Business News

No entry fee to migrate to Unified License, proposes TRAI
Rupee rally may stall with fall against US dollar, euro "Rupee rally may stall with fall against US dollar, euro"

Sources Say 'Meet To Decide If Govt Should Move Leave Plea On SC Order'

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com